Osteoarthritis Clinical Trials

Find Osteoarthritis Clinical Trials Near You

GENicular Nerve Block in KNEE Arthroplasty - The GENKNEE Trial

Status: Recruiting
Location: See location...
Intervention Type: Procedure
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

The goal of this clinical trial is to learn whether a preoperative genicular nerve block (GNB) can reduce pain after knee replacement surgery in adults with knee osteoarthritis (OA) undergoing total knee arthroplasty (TKA). It will also assess whether this treatment can reduce opioid use and improve recovery. The main questions it aims to answer are: * Does a preoperative GNB reduce pain during movement 24 hours after surgery compared with placebo? * Does it reduce opioid consumption and improve physical activity and functional outcomes after surgery? Researchers will compare patients receiving a GNB to patients receiving a placebo injection to see if the nerve block improves postoperative pain and recovery. Participants will: * Be randomly assigned to receive either a GNB or a placebo injection before surgery * Undergo standard knee replacement surgery and postoperative care * Report pain levels at regular intervals after surgery * Complete questionnaires on function, quality of life, and recovery * Wear an activity monitor to measure physical activity after surgery * Attend follow-up assessments at 1 week, 1 month, and 3 months

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 80
Healthy Volunteers: f
View:

• Symptomatic knee OA grade II-IV according to the Kellgren-Lawrence classification system scheduled for primary total knee arthroplasty

• American Society of Anesthesiologists (ASA) Physical Status grade I-III

• Able to provide written informed consent

• Able to undergo surgery under spinal anesthesia

Locations
Other Locations
Norway
Nordmøre and Romsdal Hospital (SNR)
RECRUITING
Hjelset
Contact Information
Primary
Myrthle Slettvåg Hoel, Nurse
myrthle.slettvag.hoel@helse-mr.no
+47 71120000
Backup
Tommy Frøseth Aae, MD, PhD
tommy.froseth.aae@helse-mr.no
+47 71120000
Time Frame
Start Date: 2026-07-17
Estimated Completion Date: 2029-06-01
Participants
Target number of participants: 70
Treatments
Active_comparator: Genicular nerve block (GNB)
Ultrasound-guided GNB with 5 mL of 5 mg/mL ropivacaine at the superolateral genicular nerve (SLGN), superomedial genicular nerve (SMGN), and the inferomedial genicular nerve (IMGN) with a total volume of 15 mL.
Placebo_comparator: Placebo nerve block
Ultrasound-guided placebo nerve block using 5 mL of 0.9% normal saline at the superolateral genicular nerve (SLGN), superomedial genicular nerve (SMGN), and the inferomedial genicular nerve (IMGN) with a total volume of 15 mL.
Sponsors
Collaborators: St. Olavs Hospital, The Nordmøre and Romsdal Hospital Trust, Oslo University Hospital
Leads: Helse Møre og Romsdal HF

This content was sourced from clinicaltrials.gov